Home
Advertisement & Sponsorship Options
2021/22 Media Kit
Continued Medical Education
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Network
The Episodes
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
The Episodes
National Advertising
Agenda
Directory
Join Today
Event Agenda
Video
Careers
Search
About
Advertise
Advisory Board
Contact Us
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Onco'Zine
Advertisement #1
Home
Advertisement & Sponsorship Options
2021/22 Media Kit
Continued Medical Education
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Network
The Episodes
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
The Episodes
National Advertising
Agenda
Directory
Join Today
Event Agenda
Video
Careers
US FDA Approves Gilead’s Sacituzumab Govitecan In Pre-treated HR+/HER2- Metastatic Breast Cancer
Editorial Team
-
February 3, 2023
World health Organization Launches a New Global Breast Cancer Initiative
A New Design Improves CAR-based Immunotherapies
Study: Blocking Immune Suppressor Cells in Mice with Glioblastoma Improves Survival
Stephen Spellman: Mismatched Unrelated Donors – Key to Erasing the Gap in Donor Availability in HCT
FEATURED
New Technologies in Post-surgical Wound Dressings
Brad Greer, JD
-
January 16, 2023
The Patient Journey Tech Stack: 10 Predictions for 2023
Yishai Knobel
-
January 16, 2023
Advancing Health Equity for Oncology Patients
Craig Parker
-
January 11, 2023
Racial Disparities in Lung Cancer Start With Research
Melba Newsome
-
December 14, 2022
Project Optimus: How to Prepare for Success
Julie Bullock, Pharm.D.
-
October 21, 2022
The Dictatorship of Cancer: How to Topple it in Three – Not So Easy...
Bryan Oronsky, MD. Ph.D.
-
October 21, 2022
How DNA Signatures in Stool Samples can Reduce Colorectal Cancer Deaths
Moritz Eidens, Ph.D.
-
September 22, 2022
Is Finding a Donor for All in Need of Allogeneic HCT Possible? New Modeling...
Stephen Spellman, MBS
-
September 5, 2022
Advertisement
NEWS
US FDA Approves Gilead’s Sacituzumab Govitecan In Pre-treated HR+/HER2- Metastatic Breast Cancer
Editorial Team
-
February 3, 2023
World health Organization Launches a New Global Breast Cancer Initiative
Editorial Team
-
February 3, 2023
A New Design Improves CAR-based Immunotherapies
Editorial Team
-
February 2, 2023
Study: Blocking Immune Suppressor Cells in Mice with Glioblastoma Improves Survival
Danielle Garcia
-
January 27, 2023
Stephen Spellman: Mismatched Unrelated Donors – Key to Erasing the Gap in Donor Availability...
Editorial Team
-
January 18, 2023
New Technologies in Post-surgical Wound Dressings
Brad Greer, JD
-
January 16, 2023
The Patient Journey Tech Stack: 10 Predictions for 2023
Yishai Knobel
-
January 16, 2023
Study Confirms: ‘Extreme Lack of Consistency’ Hampers the Potential of Nanosized Medicines
Danielle Garcia
-
January 12, 2023
Advancing Health Equity for Oncology Patients
Craig Parker
-
January 11, 2023
National Medical Products Administration of China Approves Mobocertinib
Danielle Garcia
-
January 11, 2023
Investigational Therapy Shows Promise Against Viral Infections After Stem Cell Transplant
Editorial Team
-
January 11, 2023
Phase 2b Study Investigates NFX-179 for the Treatment of Cutaneous Neurofibromas
Danielle Garcia
-
January 10, 2023
CONFERENCE COVERAGE
Blinatumomab Improves Overall Survival in Newly Diagnosed Adult Patient with B-lineage ALL
Danielle Garcia
-
December 13, 2022
Blood Thinners During Pregnancy in Women with Recurrent Miscarriage and Inherited Thrombophilia
Danielle Garcia
-
December 13, 2022
Zanubrutinib Demonstrates Superior PFS versus Ibrutinib in Patients Diagnosed with r/r CLL or SLL
Danielle Garcia
-
December 13, 2022
Positive Phase 1 Dose Escalation Data for Autologous PRGN-3006 UltraCAR-T® in R/R AML
Editorial Team
-
December 12, 2022
A First in Class Investigational CXCR1/2 inhibitor Demonstrates Single-agent Efficacy in MDS
Danielle Garcia
-
December 12, 2022
New Anti-mutant Calreticulin (CALR)-targeted mAb: An Important Research Milestone in MF and ET
Danielle Garcia
-
December 11, 2022
Combination Treatments in Patients with Myeloproliferative Neoplasms Reduce Burden of Disease
Danielle Garcia
-
December 10, 2022
Genetic Profiling may help Omit Radiation Therapy after Breast-conserving Surgery
Editorial Team
-
December 9, 2022
Potential Chemotherapy-free option in HER2+/HR+ mBC with Zanidatamab + Palbociclib + Fulvestrant
Editorial Team
-
December 9, 2022
Impact of Breast Conservation Therapy on Local Recurrence in Patients with Multiple Ipsilateral BC
Editorial Team
-
December 9, 2022
SERENA-2 Study Show Potential of Camizestrant as a Next-generation SERD in Endocrine Therapy
Danielle Garcia
-
December 8, 2022
Treatment Guided by CTC Count May Improve Long-term Outcomes in Patients with mBC
Editorial Team
-
December 8, 2022
Advertisement
EDITORIAL
Project Optimus: How to Prepare for Success
Julie Bullock, Pharm.D.
-
October 21, 2022
The Dictatorship of Cancer: How to Topple it in Three – Not So Easy...
Bryan Oronsky, MD. Ph.D.
-
October 21, 2022
Using Bayesian Designs to Inform Dose Recommendations in Clinical Trials
Edward Matthews
-
August 10, 2022
An Rx for American Healthcare: More Physician Entrepreneurship
Steven J. Cyr, MD
-
June 1, 2022
Bioimpedance Spectroscopy Better than Tape Measure for Preventing Breast Cancer-Related Lymphedema
Sheila Ridner, PhD, RN, FAAN
-
May 13, 2022
Cancer Moonshot Funding Should Focus on Prevention Not just Cure or Treatment
Insoo Park
-
May 12, 2022
ERIC ROSENTHAL REPORTS
Remembering Emil “Jay” Freireich—the Man Who Made Vince DeVita a ‘Believer’
Eric T. Rosenthal
-
February 13, 2021
Why Were Top HHS Officials? Interviews Thwarted by Their Press Offices?
Eric T. Rosenthal
-
March 5, 2019
EXPERT INTERVIEWS
Stephen Spellman: Mismatched Unrelated Donors – Key to Erasing the Gap in Donor Availability...
Editorial Team
-
January 18, 2023
Susanna Greer, Ph.D.: Advancing Funding for Cutting-edge Cancer Research
Editorial Team
-
November 29, 2022
The Onco’Zine Brief: A Novel Approach to Advancing Breast Cancer Therapy
Editorial Team
-
October 26, 2022
X